ERIC 2022 - European Research Initiative on CLL - ERIC

http://www.ericll.org/

 

ERIC 2022 - European Research Initiative on CLL - ERIC
Avatar

Immunological Reflections on the Origin, Nature, and Evolution of CLL

By ERIC 2022 - European Research Initiative on CLL - ERIC FEATURING Nicholas Chiorazzi
By ERIC 2022 - European Research Initiative on CLL - ERIC FEATURING Nicholas Chiorazzi
0 views
November 8, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Videos
16:41
ERIC 2022 - European Research Initiative on CLL - ERIC

My Vision of the Future of CLL

Feat. K. Rai
15:41
ERIC 2022 - European Research Initiative on CLL - ERIC

Outcomes of Patients With CLL and COVID-19 Infection

Feat. T. Chatzikonstantinou
17:51
ERIC 2022 - European Research Initiative on CLL - ERIC

Outcomes of SARS-CoV-2 Vaccination in Patients with CLL

Feat. Y. Herishanu
16:25
ERIC 2022 - European Research Initiative on CLL - ERIC

Practical Considerations on COVID-19 Management in Patients With CLL

Feat. A. Cuneo
31:28
ERIC 2022 - European Research Initiative on CLL - ERIC

The CLL Microenvironment

Feat. T. Hartmann
30:24
ERIC 2022 - European Research Initiative on CLL - ERIC

Cellular Therapies in CLL: Present and Future

Feat. M. Ruella
89:47
ERIC 2022 - European Research Initiative on CLL - ERIC

Round Table Discussion: Optimizing Treatment Outcomes in CLL

Feat. C. Moreno, B. Eichhorst, J. Seymour, A. Kater, T. Kipps
35:03
ERIC 2022 - European Research Initiative on CLL - ERIC

The Molecular Basis of Resistance to Treatment in CLL

Feat. T. Zenz
21:39
ERIC 2022 - European Research Initiative on CLL - ERIC

From Bench to Bedside: Targeting Signalling Pathways in CLL

Feat. J. Brown
24:18
ERIC 2022 - European Research Initiative on CLL - ERIC

From Bench to Bedside: Targeting Apoptosis in CLL

Feat. J. Seymour
21:28
ERIC 2022 - European Research Initiative on CLL - ERIC

Combined Inhibition of Signaling and Anti-Apoptotic Pathways in CLL

Feat. P. Hillmen
40:25
ERIC 2022 - European Research Initiative on CLL - ERIC

A Multi-Omics Perspective to the Origin, Nature, and Evolution of CLL

Feat. J. Ignacio Martín-Subero
20:55
ERIC 2022 - European Research Initiative on CLL - ERIC

The Tumor: Biomarker-Guided Treatment in CLL

Feat. O. Al-Sawaf
19:34
ERIC 2022 - European Research Initiative on CLL - ERIC

The Host: Focus on Frailty Assessment in CLL

Feat. L. Smolej
16:05
ERIC 2022 - European Research Initiative on CLL - ERIC

Patient Preferences: The Third Pillar in CLL Treatment Decisions

Feat. C. Karamanidou
33:15
ERIC 2022 - European Research Initiative on CLL - ERIC

Immunological Reflections on the Origin, Nature, and Evolution of CLL

Feat. N. Chiorazzi
17:57
ERIC 2022 - European Research Initiative on CLL - ERIC

The Nosology of CLL - An Update on CLL Diagnosis and Classification

Feat. A. Rawstron
24:05
ERIC 2022 - European Research Initiative on CLL - ERIC

Monoclonal B-Cell Lymphocytosis: From the Lab to the Clinic

Feat. A. Orfao
17:49
ERIC 2022 - European Research Initiative on CLL - ERIC

Early CLL Diagnosis: How Genomics Can Assist Us

Feat. R. Brandell